Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NewLink Genetics Corp (NASDAQ:NLNK)

23.23
Delayed Data
As of Feb 05
 -2.22 / -8.72%
Today’s Change
22.89
Today|||52-Week Range
58.73
-36.16%
Year-to-Date

Today’s Trading

Previous close25.45
Today’s open25.14
Day’s range22.89 - 26.49
Volume526,182
Average volume (3 months)533,636
Market cap$668.7M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-146.57%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio6.8
Price/Sales7.15
Price/Book3.03

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...-0.25-4.67%
TBPHTheravance Biopharma...-0.01-0.06%
RGENRepligen Corp-0.83-3.80%
HRTXHeron Therapeutics I...-1.51-7.26%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)-$0.92
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts

Partner Offers